Gambogic acid inhibits cell proliferation and induces apoptosis of human prostate cancer PC-3 cells in vitro
Tang Dong
Abstract
Tang Dong
Abstract
Objective: To study the effects of gambogic acid (GA) — an effective component extracted from gamboges on cell proliferation and apoptosis of human prostate cancer PC-3 cells. Methods: Prostate cancer PC-3 cells were treated with different concentrations of GA for 24 h in vitro. The cell proliferation was assessed by CCK-8 assay. The apoptosis was analyzed by using AO/EB double staining and flow cytometry (FCM). The expression changes of apoptosis-related proteins such as P53, Bax and Bcl-2 in PC-3 cells were evaluated by Western blotting. Results: As compared with the untreated control group, GA could not only suppress the cell proliferation of PC-3 cells, but also induce the apoptosis in a dose-dependent manner (P0.05). CCK-8 assay revealed that the proliferation of PC-3 cells was significantly inhibited when the concentration of GA was more than 1 μmol/L. AO/EB double staining showed that the nuclei became more dense and more intense orange in PC-3 cells treated with GA as compared with the untreated control PC-3 cells. Apoptosis peak was observed after treatment with GA by FCM. The expression levels of P53 and Bax were up-regulated whereas the expression level of Bcl-2 was down-regulated by GA. Conclusion: GA can significantly suppress the cell proliferation and also induce the apoptosis of human prostate cancer PC-3 cells.
OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To study the effects of gambogic acid (GA) — an effective component extracted from gamboges on cell proliferation and apoptosis of human prostate cancer PC-3 cells. Methods: Prostate cancer PC-3 cells were treated with different concentrations of GA for 24 h in vitro. The cell proliferation was assessed by CCK-8 assay. The apoptosis was analyzed by using AO/EB double staining and flow cytometry (FCM). The expression changes of apoptosis-related proteins such as P53, Bax and Bcl-2 in PC-3 cells were evaluated by Western blotting. Results: As compared with the untreated control group, GA could not only suppress the cell proliferation of PC-3 cells, but also induce the apoptosis in a dose-dependent manner (P0.05). CCK-8 assay revealed that the proliferation of PC-3 cells was significantly inhibited when the concentration of GA was more than 1 μmol/L. AO/EB double staining showed that the nuclei became more dense and more intense orange in PC-3 cells treated with GA as compared with the untreated control PC-3 cells. Apoptosis peak was observed after treatment with GA by FCM. The expression levels of P53 and Bax were up-regulated whereas the expression level of Bcl-2 was down-regulated by GA. Conclusion: GA can significantly suppress the cell proliferation and also induce the apoptosis of human prostate cancer PC-3 cells.
Key concepts: Gambogic acid, Apoptosis, Cell growth, Flow cytometry, Molecular biology, In vitro, Cell, Prostate cancer